Normand Blais

18PUBLICATIONS
42CO-AUTHORS
Molecular targetsOncology and carcinogenesis not elsewhere classifiedCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 26, 2026
Pragmatic Management of EGFR-Mutant NSCLC After Progression on Osimertinib: Canadian Expert Perspectives.

|Dec 24, 2025
A Rare Case of Metastatic Urethral Squamous Cell Carcinoma Presenting with Paraneoplastic Sweet Syndrome and Treated with Pembrolizumab.

Dan-Thanh Christine Nguyen, Zineb Hamilou, Evelyne Bonnardeaux

|Feb 25, 2025
Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study).

Ramy Samaha, Rola El Sayed, Raafat Alameddine

|Dec 22, 2023
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.

James Tankel, Jonathan Spicer, Quincy Chu

|Jul 28, 2023
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.

Martin Rupp, Fiorella Fanton-Aita, Stephanie Snow

|Jul 28, 2023
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.

Parneet K Cheema, Shantanu O Banerji, Normand Blais

Pageof 3

Frequent Collaborators

6 joint publications

Barbara Melosky

5 joint publications

Shantanu O Banerji

4 joint publications

Stephanie Snow

3 joint publications

Mustapha Tehfe